Envoy Medical, Inc. (COCH) vs Lite Strategy, Inc. (LITS)
A side-by-side comparison of Envoy Medical, Inc. and Lite Strategy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COCH
Envoy Medical, Inc.
$0.67HealthcareDelayed quote: Oct 6, 2026, 10:36 AM EDT
LITS
Lite Strategy, Inc.
$1.41HealthcareDelayed quote: Oct 6, 2026, 10:49 AM EDT
Total return — COCH vs LITS
growth of $100 · dividends reinvested · last 1yCOCH -49.5% (-49.5%/yr)LITS -69.1% (-69.1%/yr)COCH compounded faster over this window
COCH LITS
COCH vs LITS: by the numbers
- •COCH is the larger company ($51M vs $48M market cap).
- •Both run net losses; LITS's is the smaller (0.00% vs -11304.83% net margin).
Metrics side by side
Valuation
| Metric | COCH | LITS |
|---|---|---|
| P/S ratio | 247.99 | N/A |
| P/B ratio | 15.54 | 1.15 |
Profitability
| Metric | COCH | LITS |
|---|---|---|
| Gross margin | -262.66% | 0.00% |
| Operating margin | -9240.66% | 0.00% |
| Net margin | -11304.83% | 0.00% |
| ROE | -708.48% | -170.94% |
| ROIC | -208.76% | -30.75% |
Growth (annualized)
| Metric | COCH | LITS |
|---|---|---|
| Total return CAGR (5Y) | -41.73% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.